Kalvista Pharmaceuticals Inc (KALV)
SG&A Expenses
$58.61M
Quarterly · Period ending: · USD
KALV SG&A Expenses
Latest reported$58.61Mperiod ending
Latest reported$58.61Mperiod ending
KALV Quarterly SG&A Expenses ($368.00K → $58.61M)
Quarterly SG&A Expenses
High-resolution chart · PNG
KALV sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 58,611,000 | |
| 48,440,000 | |
| 46,517,000 | |
| 44,683,000 | |
| 39,139,000 | |
| 30,346,000 | |
| 29,201,000 | |
| 17,601,000 | |
| 23,207,000 | |
| 10,421,000 | |
| 10,657,000 | |
| 9,786,000 | |
| 7,777,000 | |
| 6,882,000 | |
| 7,806,000 | |
| 8,130,000 | |
| 7,598,000 | |
| 6,945,000 | |
| 6,057,000 | |
| 5,847,000 | |
| 6,165,000 | |
| 3,560,000 | |
| 3,633,000 | |
| 3,278,000 | |
| 3,296,000 | |
| 3,068,000 | |
| 3,420,000 | |
| 3,247,000 | |
| 3,047,000 | |
| 2,900,000 | |
| 2,609,000 | |
| 2,371,000 | |
| 1,957,000 | |
| 2,129,000 | |
| 2,703,000 | |
| 2,073,000 | |
| 2,204,000 | |
| 5,026,000 | |
| 2,080,000 | |
| 2,080,000 | |
| 1,543,000 | |
| 1,317,000 | |
| 1,373,000 | |
| 1,170,000 | |
| 1,006,000 | |
| 794,000 | |
| 1,490,000 | |
| 691,000 | |
| 437,000 | |
| 368,000 |